Filing Flows › Silgan Holdings (SLGN) › Dispensing and Specialty Closures revenue
Silgan Holdings (SLGN) Dispensing and Specialty Closures revenue by quarter
Silgan Holdings' Dispensing and Specialty Closures revenue was $699M in Q3 2026 (third quarter 2026), -2% from Q2 2026. Over the last 7 quarters it ranged from $644M (Q4 2025) to $714M (Q2 2026).
| Quarter | Dispensing and Specialty Closures revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $699M | -2% | +1% |
| Q2 2026 | $714M | +4% | +2% |
| Q1 2026 | $685M | +6% | +2% |
| Q4 2025 | $644M | -7% | — |
| Q3 2025 | $690M | -2% | — |
| Q2 2025 | $702M | +5% | — |
| Q1 2025 | $671M | — | — |
Q3 2026 at a glance
Silgan Holdings, Q3 2026: revenue $2.0B (+2% year over year), operating margin 7.1%, net earnings $105M, operating cash flow $347M. The chart follows the revenue to costs, profit and cash.
Questions
What is Silgan Holdings' Dispensing and Specialty Closures revenue?
Silgan Holdings' Dispensing and Specialty Closures revenue was $699M in Q3 2026 (third quarter 2026), -2% from Q2 2026.
How has Silgan Holdings' Dispensing and Specialty Closures revenue changed?
Over the last 7 quarters it ranged from $644M (Q4 2025) to $714M (Q2 2026).